Lighting Up Life in Real Time

In recent years scientists have exploited the light-generating capability of luciferase in applications ranging from apoptosis detection to DNA quantitation. Now Alameda, Calif.-based Xenogen has taken this useful enzyme one step further, with a luciferase-based system for studying infectious diseases, cancer, and metabolic diseases in living animals in real time. Xenogen has developed Bioware™ animal models, in which pathogens, target genes, or tumor cells are tagged with luciferase, whi

Written byAileen Constans
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Xenogen has developed Bioware™ animal models, in which pathogens, target genes, or tumor cells are tagged with luciferase, which emits light when the pathogen or gene is present or cells are growing. The company also offers LPTA™ transgenic animals modified with gene-specific luciferase reporters that permit gene expression tracking throughout the animal's growth and development. "When the genes are expressed or when the pathogen or the tumor cell is present, or growing in the body of an animal," says Pam Contag, Xenogen's president, "we can actually image that across the whole body of the animal with spatial resolution, over time, and with a great degree of sensitivity."

Researchers monitor the animals with Xenogen's IVIS™ Imaging System, which combines a CCD camera with an imaging chamber optimized for detecting bioluminescence in Xenogen's animal models. Contag says Xenogen improved the CCD system's sensitivity 100-fold to detect the very low levels of light ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies